BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30830284)

  • 1. Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y.
    Godel T; Bäumer P; Stumpfe K; Muschol N; Kronlage M; Brunnée M; Kollmer J; Heiland S; Bendszus M; Mautner VF
    J Neurol; 2019 Jun; 266(6):1332-1339. PubMed ID: 30830284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human dorsal root ganglion in vivo morphometry and perfusion in Fabry painful neuropathy.
    Godel T; Bäumer P; Pham M; Köhn A; Muschol N; Kronlage M; Kollmer J; Heiland S; Bendszus M; Mautner VF
    Neurology; 2017 Sep; 89(12):1274-1282. PubMed ID: 28835396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dorsal root ganglia in vivo morphometry and perfusion in female patients with Fabry disease.
    Godel T; Köhn A; Muschol N; Kronlage M; Schwarz D; Kollmer J; Heiland S; Bendszus M; Mautner VF; Bäumer P
    J Neurol; 2018 Nov; 265(11):2723-2729. PubMed ID: 30209652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Peripheral Nervous System Alterations in Patients with the Fabry Related
    Godel T; V Cossel K; Friedrich RE; Glatzel M; Canaan-Kühl S; Duning T; Kronlage M; Heiland S; Bendszus M; Muschol N; Mautner VF
    Diagnostics (Basel); 2020 Nov; 10(12):. PubMed ID: 33266233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabry disease due to D313Y and novel GLA mutations.
    Koulousios K; Stylianou K; Pateinakis P; Zamanakou M; Loules G; Manou E; Kyriklidou P; Katsinas C; Ouzouni A; Kyriazis J; Speletas M; Germenis AE
    BMJ Open; 2017 Oct; 7(10):e017098. PubMed ID: 28988177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mutation p.D313Y is associated with organ manifestation in Fabry disease.
    du Moulin M; Koehn AF; Golsari A; Dulz S; Atiskova Y; Patten M; Münch J; Avanesov M; Ullrich K; Muschol N
    Clin Genet; 2017 Nov; 92(5):528-533. PubMed ID: 28276057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y.
    Oder D; Üçeyler N; Liu D; Hu K; Petritsch B; Sommer C; Ertl G; Wanner C; Nordbeck P
    BMJ Open; 2016 Apr; 6(4):e010422. PubMed ID: 27059467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral nervous system alterations in infant and adult neurofibromatosis type 2.
    Godel T; Bäumer P; Farschtschi S; Gugel I; Kronlage M; Hofstadler B; Heiland S; Gelderblom M; Bendszus M; Mautner VF
    Neurology; 2019 Aug; 93(6):e590-e598. PubMed ID: 31300546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease.
    Hasholt L; Ballegaard M; Bundgaard H; Christiansen M; Law I; Lund AM; Norremolle A; Krogh Rasmussen A; Ravn K; Tumer Z; Wibrand F; Feldt-Rasmussen U
    Scand J Clin Lab Invest; 2017 Dec; 77(8):617-621. PubMed ID: 29037082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of small fiber neuropathy in patients carrying the non-classical Fabry variant p.D313Y.
    von Cossel K; Muschol N; Friedrich RE; Glatzel M; Ammer L; Lohmöller B; Bendszus M; Mautner VF; Godel T
    Muscle Nerve; 2021 May; 63(5):745-750. PubMed ID: 33543778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dorsal root ganglion magnetic resonance imaging biomarker correlations with pain in Fabry disease.
    Schindehütte M; Weiner S; Klug K; Hölzli L; Nauroth-Kreß C; Hessenauer F; Kampf T; Homola GA; Nordbeck P; Wanner C; Sommer C; Üçeyler N; Pham M
    Brain Commun; 2024; 6(3):fcae155. PubMed ID: 38751382
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Palaiodimou L; Stefanou MI; Bakola E; Papadopoulou M; Kokotis P; Vrettou AR; Kapsia E; Petras D; Anastasakis A; Xifaras N; Karachaliou E; Touloumi G; Vlachopoulos C; Boletis IN; Giannopoulos S; Tsivgoulis G; Zompola C
    Neurology; 2022 Nov; 99(19):e2188-e2200. PubMed ID: 36344272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multifocal white matter lesions associated with the D313Y mutation of the α-galactosidase A gene.
    Lenders M; Duning T; Schelleckes M; Schmitz B; Stander S; Rolfs A; Brand SM; Brand E
    PLoS One; 2013; 8(2):e55565. PubMed ID: 23393592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D313Y variant in two related end-stage renal disease patients - Pathogenic or not yet?
    Vicente R; Santos I; Coimbra M; Santos J; Santos R; Amoedo M; Pires C
    Nefrologia (Engl Ed); 2023; 43(5):636-639. PubMed ID: 36517364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.
    Froissart R; Guffon N; Vanier MT; Desnick RJ; Maire I
    Mol Genet Metab; 2003 Nov; 80(3):307-14. PubMed ID: 14680977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
    Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
    Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dorsal root ganglia volume differentiates schwannomatosis and neurofibromatosis 2.
    Godel T; Mautner VF; Farschtschi S; Pham M; Schwarz D; Kronlage M; Gugel I; Heiland S; Bendszus M; Bäumer P
    Ann Neurol; 2018 Apr; 83(4):854-857. PubMed ID: 29469988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nationwide screening for Fabry disease in unselected stroke patients.
    Tomek A; Petra R; Paulasová Schwabová J; Olšerová A; Škorňa M; Nevšímalová M; Šimůnek L; Herzig R; Fafejtová Š; Mikulenka P; Táboříková A; Neumann J; Brzezny R; Sobolová H; Bartoník J; Václavík D; Vachová M; Bechyně K; Havlíková H; Prax T; Šaňák D; Černíková I; Ondečková I; Procházka P; Rajner J; Škoda M; Novák J; Škoda O; Bar M; Mikulík R; Dostálová G; Linhart A;
    PLoS One; 2021; 16(12):e0260601. PubMed ID: 34905550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mutation D313Y may be associated with nervous system manifestations in Fabry disease.
    Zompola C; Palaiodimou L; Kokotis P; Papadopoulou M; Theodorou A; Sabanis N; Theodoroula E; Papathanasiou M; Tsivgoulis G; Chroni E
    J Neurol Sci; 2020 May; 412():116757. PubMed ID: 32109691
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term Follow-up and Histological Correlation of Peripheral Nervous System Alterations in Neurofibromatosis Type 2.
    Godel T; Bäumer P; Farschtschi S; Püschel K; Hofstadler B; Heiland S; Gelderblom M; Bendszus M; Hagel C; Mautner VF
    Clin Neuroradiol; 2022 Mar; 32(1):277-285. PubMed ID: 34652463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.